All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @kroshii on TikTok · 44s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @kroshii's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00say it with me now.
  2. 0:02Here does not change your facial structure.
  3. 0:07If you look at me two weeks out from my show,
  4. 0:10I think, hmm, I can see all of her bone structure in her face.
  5. 0:14Hmm, maybe consider that she's under 10% body fat
  6. 0:18and be a little strange if her face was fat
  7. 0:23while the rest of her body was shredded.
  8. 0:26You know, that'll be a little weird.
  9. 0:28Yes, women who take steroids look like men.
  10. 0:30Steroids raise your testosterone, cause facial muscle growth,
  11. 0:33water retention, and fat redistribution.
  12. 0:35Their joggers book your their cheeks get wider
  13. 0:37and their whole face starts to harden up.
  14. 0:39That's why women who take gears start looking masculine.
  15. 0:41You can literally spot it from a mile away.

@kroshii's testosterone virilization claims, fact-checked

Kroshi

TikTok creator

66.1K viewsWatch on TikTok

Quick answer

The creator accurately describes androgenic effects on facial soft tissue, including fat redistribution and muscle hypertrophy, as mechanisms behind masculinizing facial changes in women using anabolic steroids at supraphysiologic doses. These effects are dose-dependent and well-documented in both AAS-using athlete populations and gender-affirming testosterone therapy research. Women receiving therapeutic testosterone for hypogonadism at physiologic replacement doses are not the same clinical population being described, and the video's placement in a TRT category risks misleading that audience.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @kroshii's testosterone virilization claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@kroshii's testosterone virilization claims, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@kroshii's testosterone virilization claims, fact-checked" from Kroshi. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator accurately describes androgenic effects on facial soft tissue, including fat redistribution and muscle hypertrophy, as mechanisms behind masculinizing facial changes in women using anabolic steroids at supraphysiologic doses.

The reason this review is not generic is the source wording and the canonical claim label "trt female bodybuilders anabolic steroids how high dose testo." In this clip, the useful excerpt is: "say it with me now." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Van de Grift et al.
People who land here are usually trying to understand whether the Testosterone claim is evidence-backed, safe, and relevant to their own situation.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator accurately describes androgenic effects on facial soft tissue, including fat redistribution and muscle hypertrophy, as mechanisms behind masculinizing facial changes in women using anabolic steroids at supraphysiologic doses.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator accurately describes androgenic effects on facial soft tissue, including fat redistribution and muscle hypertrophy, as mechanisms behind masculinizing facial changes in women using anabolic steroids at supraphysiologic doses. These effects are dose-dependent and well-documented in both AAS-using athlete populations and gender-affirming testosterone therapy research. Women receiving therapeutic testosterone for hypogonadism at physiologic replacement doses are not the same clinical population being described, and the video's placement in a TRT category risks misleading that audience.
  • Androgen receptors are present in facial adipose tissue and muscles including the masseter, making testosterone-driven facial soft tissue changes biologically plausible and documented (Mulhall et al., 2021, Andrology).
  • Van de Grift et al. (2019, JAMA Dermatology) found measurable facial changes in trans men on testosterone therapy at 12 months, attributed primarily to soft tissue redistribution, not cortical bone remodeling.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Androgen receptors are present in facial adipose tissue and muscles including the masseter, making testosterone-driven facial soft tissue changes biologically plausible and documented (Mulhall et al., 2021, Andrology).
  • Van de Grift et al. (2019, JAMA Dermatology) found measurable facial changes in trans men on testosterone therapy at 12 months, attributed primarily to soft tissue redistribution, not cortical bone remodeling.
  • Handelsman et al. (2020, Endocrine Reviews) confirmed androgenic phenotypic effects in women scale with androgen exposure level, meaning therapeutic TRT doses and supraphysiologic bodybuilding doses produce very different outcomes.
  • Water retention from aromatizing anabolic compounds can cause facial puffiness that may be misread as structural masculinization, adding a confounding variable the creator does not address.
  • No published research supports reliable visual identification of AAS use from facial appearance alone. Individual variability in androgen receptor sensitivity, compound choice, and dose makes the 'spot it from a mile away' claim unsupported.
  • Women using therapeutic testosterone for diagnosed hypogonadism at physiologic replacement doses are a clinically distinct population from competitive female bodybuilders using supraphysiologic AAS. This video does not make that distinction.
  • The creator correctly identifies the mechanism of androgenic facial changes but undermines accuracy by conflating low body fat effects with drug effects in a way that reads as rhetorical deflection rather than scientific clarification.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @kroshii actually say?

The creator made two distinct claims worth separating. First, she dismissed the idea that low body fat changes facial appearance, arguing that visible bone structure at under 10% body fat is just leanness, not a drug effect. Second, she made a confident causal claim: steroids cause "facial muscle growth, water retention, and fat redistribution" that makes women's faces look masculine. She said you can "literally spot it from a mile away." So which part holds up?

The second claim is the one doing real scientific work here. She's describing androgenic effects on soft tissue and fat distribution in the face, which is actually a legitimate physiological mechanism. The first claim, the dismissal about bone structure, is where things get more complicated.

Does the science back this up?

Partially, yes. The claim that supraphysiologic androgen exposure causes facial changes in women has real support. A 2021 review by Mulhall et al. in Andrology documented soft tissue hypertrophy and fat redistribution as documented effects of anabolic-androgenic steroids (AAS) in women. Androgen receptors are present in facial adipose tissue and in muscles like the masseter, so testosterone acting on those tissues is biologically plausible, not speculation.

Water retention from AAS use, particularly with compounds that aromatize or have glucocorticoid-like effects, can cause facial puffiness that some interpret as structural change. The buccal fat redistribution she describes, "cheeks get wider," is documented in gender-affirming testosterone therapy literature. A 2019 study by van de Grift et al. in JAMA Dermatology found measurable facial structure changes in trans men using testosterone over 12 months, driven largely by soft tissue, not bone.

What did they get wrong (or right)?

She got the mechanism mostly right but overclaimed the certainty. Saying you can "spot it from a mile away" implies a precision that the research doesn't support. These changes exist on a spectrum tied to dose, duration, compound type, and individual androgen sensitivity. Not every woman using AAS develops visible facial masculinization.

The bone structure dismissal is where she's more slippery. She implies that anyone suggesting facial bone changes from steroids is wrong, but she's conflating two different claims. Acute AAS use in adult women does not remodel cortical bone significantly, that part is fair. But she uses that to deflect from the documented soft tissue effects, which she then correctly describes two sentences later. It reads as a rhetorical move more than a scientific one.

  • Right: AAS cause fat redistribution, water retention, and soft tissue changes in the face.
  • Right: Low body fat reveals underlying facial structure independently of drug use.
  • Misleading: Framing the bone structure point as if it refutes the broader masculinization argument.
  • Overclaimed: "Spot it from a mile away" implies universal, obvious effects that don't match individual variability in the data.

What should you actually know?

If you're evaluating this for clinical or personal relevance, the honest answer is that the creator is describing real androgenic effects while also using competitive bodybuilding framing that isn't generalizable to, say, a woman on therapeutic testosterone for hypogonadism. Therapeutic TRT doses in women are typically in the range used to restore physiologic levels, which produces very different outcomes than the supraphysiologic doses used in competitive bodybuilding. The masculinizing effects she describes are dose-dependent.

A 2020 paper by Handelsman et al. in Endocrine Reviews spelled this out clearly: feminizing or masculinizing phenotypic effects in women track closely with androgen exposure above or below physiologic thresholds. Women on appropriately dosed TRT for documented hypogonadism are not the same population as female competitive bodybuilders using anabolic compounds at multiples of physiologic levels. Conflating those two groups, which this video implicitly does by sitting in the TRT category, is clinically irresponsible.

Bottom line on this video

The creator knows her physiology well enough to get the mechanism right. The soft tissue explanation for facial masculinization is real science, not broscience. But the framing, the confident visual identification claim, the rhetorical bone-structure deflection, and the lack of any dose or context caveats, makes this more persuasive content than accurate health information. It belongs in the "mostly right about one thing, misleading about the bigger picture" category.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Kroshi · TikTok creator

66.1K views on this video

Female Bodybuilders & Anabolic Steroids: How High-Dose Testosterone Changes Women’s Faces and Mass

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about androgen receptors?

Androgen receptors are present in facial adipose tissue and muscles including the masseter, making testosterone-driven facial soft tissue changes biologically plausible and documented (Mulhall et al., 2021, Andrology).

What does the video say about van de grift et al. (2019, jama dermatology) found measurable?

Van de Grift et al. (2019, JAMA Dermatology) found measurable facial changes in trans men on testosterone therapy at 12 months, attributed primarily to soft tissue redistribution, not cortical bone remodeling.

What does the video say about handelsman et al. (2020, endocrine reviews) confirmed?

Handelsman et al. (2020, Endocrine Reviews) confirmed androgenic phenotypic effects in women scale with androgen exposure level, meaning therapeutic TRT doses and supraphysiologic bodybuilding doses produce very different outcomes.

What does the video say about water retention from aromatizing anabolic compounds can cause facial puffiness?

Water retention from aromatizing anabolic compounds can cause facial puffiness that may be misread as structural masculinization, adding a confounding variable the creator does not address.

What does the video say about no published research supports reliable visual identification of aas use?

No published research supports reliable visual identification of AAS use from facial appearance alone. Individual variability in androgen receptor sensitivity, compound choice, and dose makes the 'spot it from a mile away' claim unsupported.

What does the video say about women using therapeutic testosterone for diagnosed hypogonadism at physiologic replacement?

Women using therapeutic testosterone for diagnosed hypogonadism at physiologic replacement doses are a clinically distinct population from competitive female bodybuilders using supraphysiologic AAS. This video does not make that distinction.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Not medical advice. This video was made by Kroshi, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.